Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating margin is N/A as of Tuesday, October 6, 2026.
OPERATING MARGIN
N/A
Market Cap
$3.48M
Operating Margin
-364.24%
TTM Avg
-350.71%
3Y Avg
-763.84%
5Y Avg
-1461.60%
Market Cap
$3.47M
Operating Margin
-446.70%
TTM Avg
-461.82%
3Y Avg
-487.15%
5Y Avg
-381.78%
Market Cap
$3.44M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
-518.01%
5Y Avg
-1135.32%
Market Cap
$3.37M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$3.94M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
-229.94%
5Y Avg
-288.65%
Market Cap
$3.13M
Operating Margin
0.00%
TTM Avg
-11613.39%
3Y Avg
-11298.29%
5Y Avg
-8806.57%
Market Cap
$3.09M
Operating Margin
-4350.05%
TTM Avg
-3615.82%
3Y Avg
-8354.24%
5Y Avg
-15697.02%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Eocene Ltd. (EOCN) | $3.59M | N/A | N/A | N/A | N/A |
| Evogene Ltd. (EVGN)vs › | $3.48M | -364.24% | -350.71% | -763.84% | -1461.60% |
| IceCure Medical Ltd (ICCM)vs › | $3.47M | -446.70% | -461.82% | -487.15% | -381.78% |
| Aethlon Medical, Inc. (AEMD)vs › | $3.44M | 0.00% | 0.00% | -518.01% | -1135.32% |
| Cadrenal Therapeutics, Inc. Common Stock (CVKD)vs › | $3.37M | 0.00% | 0.00% | 0.00% | 0.00% |
| Aptevo Therapeutics Inc. (APVO)vs › | $3.94M | 0.00% | 0.00% | -229.94% | -288.65% |
| Adagio Medical Holdings, Inc. (ADGM)vs › | $3.13M | 0.00% | -11613.39% | -11298.29% | -8806.57% |
| BioRestorative Therapies, Inc. (BRTX)vs › | $3.09M | -4350.05% | -3615.82% | -8354.24% | -15697.02% |
| GRI Bio, Inc. (GRI)vs › | $4.18M | N/A | 0.00% | 0.00% | -243.17% |
| 20/20 Biolabs Inc. (AIDX)vs › | $4.32M | -162.87% | -242.97% | -229.35% | -164.06% |
Gross Margin
N/A
Operating Margin
N/A
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
